Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,312,991 shares of the real estate investment trust’s stock after acquiring an additional 426,074 shares during the period. JPMorgan Chase & Co. owned about 4.36% of Sabra Health Care REIT worth $178,621,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in SBRA. Rockefeller Capital Management L.P. boosted its holdings in Sabra Health Care REIT by 4.5% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 15,369 shares of the real estate investment trust’s stock valued at $286,000 after purchasing an additional 655 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Sabra Health Care REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 656 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Sabra Health Care REIT by 0.4% in the fourth quarter. Janney Montgomery Scott LLC now owns 177,161 shares of the real estate investment trust’s stock valued at $3,068,000 after buying an additional 763 shares in the last quarter. Louisiana State Employees Retirement System raised its position in Sabra Health Care REIT by 1.2% in the fourth quarter. Louisiana State Employees Retirement System now owns 65,700 shares of the real estate investment trust’s stock worth $1,138,000 after acquiring an additional 800 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its holdings in Sabra Health Care REIT by 1.7% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 48,185 shares of the real estate investment trust’s stock valued at $835,000 after acquiring an additional 800 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Health Care REIT Stock Performance

NASDAQ:SBRA opened at $17.47 on Tuesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The firm has a market cap of $4.16 billion, a PE ratio of 32.96, a P/E/G ratio of 1.97 and a beta of 1.27. The firm has a 50 day simple moving average of $16.84 and a 200-day simple moving average of $17.67. Sabra Health Care REIT, Inc. has a 1-year low of $13.31 and a 1-year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The company had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. On average, equities analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.87%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is currently 226.42%.

Analysts Set New Price Targets

SBRA has been the subject of several recent analyst reports. Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $19.33.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.